Drugs Update: New FDA approved Drugs

FDA pushed out 4 big approvals. Cholesterol-reducing PCSK9 inhibitors: Sanofi and Regeneron’s Praluent Technivie (ombitasvir, paritaprevir and ritonavir) for Chronic Hepatitis C Genotype 4 Infections Odomzo (sonidegib), a hedgehog pathway inhibitor for basal cell carcinoma Kyprolis (carfilzomib) for Combination Treatment of Patients with Relapsed Multiple Myeloma Praluent (alirocumab) to Treat Certain Patients with High Cholesterol Daklinza (daclatasvir) for… Continue reading Drugs Update: New FDA approved Drugs